Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is antithrombotic therapy a risk-free and beneficial treatment for patients with heart failure?

Nature Clinical Practice Cardiovascular Medicine volume 1, pages 80–81 (2004)Cite this article

boxed-textCleland et al. (2004) The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 148: 157–164

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Loh E et al. (1997) Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 336: 251–257

    Article  CAS  Google Scholar 

  2. Teo KK et al. (2002) Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet 360: 1037–1043

    Article  CAS  Google Scholar 

  3. Massie BM et al. (2004) The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail 10: 101–112

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Cardiology at the University Medical Center St Radboud, Nijmegen, The Netherlands

    Freek WA Verheugt

Authors
  1. Freek WA Verheugt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Freek WA Verheugt.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verheugt, F. Is antithrombotic therapy a risk-free and beneficial treatment for patients with heart failure?. Nat Rev Cardiol 1, 80–81 (2004). https://doi.org/10.1038/ncpcardio0039

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0039

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing